Bruce F Wesson - Net Worth and Insider Trading
Bruce F Wesson Net Worth
The estimated net worth of Bruce F Wesson is at least $827,349 dollars as of 2024-11-05. Bruce F Wesson is the Director of Derma Sciences Inc and owns about 94,963 shares of Derma Sciences Inc (DSCI) stock worth over $664,741. Bruce F Wesson is the Director of MedAssets Inc and owns about 5,168 shares of MedAssets Inc (MDAS) stock worth over $162,017. Bruce F Wesson is also the Director of Acura Pharmaceuticals Inc and owns about 394,404 shares of Acura Pharmaceuticals Inc (ACUR) stock worth over $592. Details can be seen in Bruce F Wesson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Bruce F Wesson has not made any transactions after 2017-12-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Bruce F Wesson
Bruce F Wesson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Bruce F Wesson owns 4 companies in total, including Acura Pharmaceuticals Inc (ACUR) , Derma Sciences Inc (DSCI) , and MedAssets Inc (MDAS) among others .
Click here to see the complete history of Bruce F Wesson’s form 4 insider trades.
Insider Ownership Summary of Bruce F Wesson
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ACUR | Acura Pharmaceuticals Inc | 2020-01-02 | director |
| DSCI | Derma Sciences Inc | 2016-05-31 | other: Former Director |
| MDAS | MedAssets Inc | 2016-01-27 | director |
 | | 2008-02-28 | director |
Bruce F Wesson Latest Holdings Summary
Bruce F Wesson currently owns a total of 3 stocks. Among these stocks, Bruce F Wesson owns 94,963 shares of Derma Sciences Inc (DSCI) as of August 13, 2015, with a value of $664,741 and a weighting of 80.35%. Bruce F Wesson owns 5,168 shares of MedAssets Inc (MDAS) as of November 21, 2013, with a value of $162,017 and a weighting of 19.58%. Bruce F Wesson also owns 394,404 shares of Acura Pharmaceuticals Inc (ACUR) as of December 14, 2017, with a value of $592 and a weighting of 0.07%.
Latest Holdings of Bruce F Wesson
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DSCI | Derma Sciences Inc | 2015-08-13 | 94,963 | 7.00 | 664,741 |
| MDAS | MedAssets Inc | 2013-11-21 | 5,168 | 31.35 | 162,017 |
| ACUR | Acura Pharmaceuticals Inc | 2017-12-14 | 394,404 | 0.00 | 592 |
Holding Weightings of Bruce F Wesson
Bruce F Wesson Form 4 Trading Tracker
According to the SEC Form 4 filings, Bruce F Wesson has made a total of 0 transactions in Derma Sciences Inc (DSCI) over the past 5 years. The most-recent trade in Derma Sciences Inc is the acquisition of 10,000 shares on August 13, 2015, which cost Bruce F Wesson around $65,800.
According to the SEC Form 4 filings, Bruce F Wesson has made a total of 0 transactions in MedAssets Inc (MDAS) over the past 5 years. The most-recent trade in MedAssets Inc is the sale of 60,263 shares on November 21, 2013, which brought Bruce F Wesson around $1 Million.
According to the SEC Form 4 filings, Bruce F Wesson has made a total of 0 transactions in Acura Pharmaceuticals Inc (ACUR) over the past 5 years. The most-recent trade in Acura Pharmaceuticals Inc is the acquisition of 335,734 shares on December 14, 2017, which cost Bruce F Wesson around $33,573.
Insider Trading History of Bruce F Wesson
- 1
Bruce F Wesson Trading Performance
GuruFocus tracks the stock performance after each of Bruce F Wesson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Bruce F Wesson is 18.96%. GuruFocus also compares Bruce F Wesson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Bruce F Wesson within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Bruce F Wesson's insider trading performs compared to the benchmark.
Performance of Bruce F Wesson
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 11.56 | | | | | |
| Relative Return to S&P 500(%) | 8.17 | | | | | |
Bruce F Wesson Ownership Network
Ownership Network List of Bruce F Wesson
Ownership Network Relation of Bruce F Wesson
Bruce F Wesson Owned Company Details
What does Acura Pharmaceuticals Inc do?
Who are the key executives at Acura Pharmaceuticals Inc?
Bruce F Wesson is the director of Acura Pharmaceuticals Inc. Other key executives at Acura Pharmaceuticals Inc include VP & Corporate Development James F Emigh , VP & Treasurer & Controller Robert A Seiser , and President & CEO Robert B Jones .
Acura Pharmaceuticals Inc (ACUR) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Acura Pharmaceuticals Inc (ACUR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acura Pharmaceuticals Inc (ACUR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Acura Pharmaceuticals Inc (ACUR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Acura Pharmaceuticals Inc Insider Transactions
Bruce F Wesson Mailing Address
Above is the net worth, insider trading, and ownership report for Bruce F Wesson. You might contact Bruce F Wesson via mailing address: 1827 Pacific St Brooklyn Ny 11233.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
